Muye He
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems 4
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery 5
-
- Cancer Research and Treatments 3
-
- RNA Interference and Gene Delivery 5
-
- CAR-T cell therapy research 4
-
- Immunotherapy and Immune Responses 4
-
- Virus-based gene therapy research 3
-
- Tissue Engineering and Regenerative Medicine 3
- Co-authors
- Feng GaoXinyu HouMinbo LanRongjun ChenYuzheng ZhaoYanzuo ChenLei HuangKaiyan Lou
- Journals
- International Journal of Pharmaceutics (4 papers)Journal of Controlled Release (4 papers)International Journal of Nanomedicine (3 papers)
- Partner nations
- ChinaUnited KingdomUnited States
In The Last Decade
Muye He
23 papers receiving 435 citations
Peers
Comparison fields: 5 of 78
- Pharmaceutical Science 85
- Biomaterials 163
- Molecular Medicine 31
- Biomedical Engineering 180
- Biotechnology 23
Countries citing papers authored by Muye He
This map shows the geographic impact of Muye He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muye He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muye He more than expected).
Fields of papers citing papers by Muye He
This network shows the impact of papers produced by Muye He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muye He. The network helps show where Muye He may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Muye He, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 6 | |
| 2 | 2024 | 12 | |
| 3 | 2024 | 13 | |
| 4 | 2024 | 3 | |
| 5 | 2023 | 6 | |
| 6 | 2023 | 6 | |
| 7 | 2023 | 3 | |
| 8 | 2022 | 4 | |
| 9 | 2022 | 3 | |
| 10 | 2022 | 9 | |
| 11 | 2021 | 12 | |
| 12 | 2021 | 47 | |
| 13 | 2020 | 22 | |
| 14 | 2019 | 5 | |
| 15 | 2019 | 24 | |
| 16 | 2018 | 41 | |
| 17 | 2018 | 4 | |
| 18 | 2018 | 34 | |
| 19 | 2017 | 37 | |
| 20 | 2017 | 10 |
About Muye He
Muye He is a scholar working on Pharmaceutical Science, Biomaterials, Biotechnology, Immunology and Occupational Therapy, having authored 24 papers that have together received 440 indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (5 papers), Nanoparticle-Based Drug Delivery (5 papers), CAR-T cell therapy research (4 papers), Immunotherapy and Immune Responses (4 papers), Advanced Drug Delivery Systems (4 papers), Virus-based gene therapy research (3 papers), Cancer Research and Treatments (3 papers) and Tissue Engineering and Regenerative Medicine (3 papers). The work is most often cited by research in Pharmaceutical Science (85 citations), Biomaterials (163 citations), Molecular Medicine (31 citations), Biomedical Engineering (180 citations) and Biotechnology (23 citations). Muye He has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Feng Gao, Xinyu Hou, Minbo Lan, Rongjun Chen, Yuzheng Zhao, Yanzuo Chen, Lei Huang, Kaiyan Lou, Yan Wang and Junru Wu. Their work appears in journals such as International Journal of Pharmaceutics, Journal of Controlled Release, International Journal of Nanomedicine, Asian Journal of Pharmaceutical Sciences and Molecular Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.